e-Drug3D

426

LOXAPINE


INN
LOXAPINE

cas 1977-10-2
CLASS

NERVOUS SYSTEM
ANXIOLYTIC
DIBENZOXAZEPINE ANTIPSYCHOTIC AGENTS
DOPAMINE ANTAGONISTS
TREATMENT OF SCHIZOPHRENIA

ROUTE (list)

ORAL INJECTION INHALATION

ATC code

N05AH01

PK parameters

Tmax 1.88 HOUR
Cl 48.4 LITER / HOUR
PPB 96.6 PERCENT
t1/2 7.3 HOUR

Target

TARGET D(2) DOPAMINE RECEPTOR
SEROTONIN 5-HT2 RECEPTOR (PMID24937085)

DrugCentral

D(2) dopamine receptor UNIPROT P14416 DRD2

5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A

Download SDF file 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,5]benzoxazepine

Formula:
C18H18ClN3O

Calculated chemical properties:

MW 327.80
NB_atoms 23
XLogP 3.77
PSA 27.447
NB_HD 0
NB_HA 4
fsp3 0.28
Lipinski(0=no;1=yes) 1

FDA
NDA 017525 (pdf not found) INN (LOXAPINE SUCCINATE) LOXITANE (TEVA BRANDED PHARM) APPROVAL= AP YEAR= 1975 DISCONTINUED
NDA 017658 (pdf not found) INN (LOXAPINE HYDROCHLORIDE) LOXITANE C (TEVA BRANDED PHARM) APPROVAL= AP YEAR= 1976 DISCONTINUED
NDA 018039 (pdf not found) INN (LOXAPINE HYDROCHLORIDE) LOXITANE IM (ACTAVIS LABS UT INC) APPROVAL= AP YEAR= 1979 DISCONTINUED
NDA 072062 (pdf not found) INN (LOXAPINE SUCCINATE) LOXAPINE SUCCINATE (WATSON LABS) APPROVAL= AP YEAR= 1988
NDA 072204 (pdf not found) INN (LOXAPINE SUCCINATE) LOXAPINE SUCCINATE (WATSON LABS) APPROVAL= AP YEAR= 1988
NDA 072205 (pdf not found) INN (LOXAPINE SUCCINATE) LOXAPINE SUCCINATE (WATSON LABS) APPROVAL= AP YEAR= 1988
NDA 072206 (pdf not found) INN (LOXAPINE SUCCINATE) LOXAPINE SUCCINATE (WATSON LABS) APPROVAL= AP YEAR= 1988
NDA 076762 (pdf not found) INN (LOXAPINE SUCCINATE) LOXAPINE SUCCINATE (RISING) APPROVAL= AP YEAR= 2004 DISCONTINUED
NDA 076868 (pdf not found) INN (LOXAPINE SUCCINATE) LOXAPINE SUCCINATE (ELITE LABS INC) APPROVAL= AP YEAR= 2005
NDA 090695 (pdf not found) INN (LOXAPINE SUCCINATE) LOXAPINE SUCCINATE (LANNETT CO INC) APPROVAL= AP YEAR= 2011
NDA 022549 (pdf not found) INN (LOXAPINE) ADASUVE (ALEXZA PHARMS) APPROVAL= AP YEAR= 2012

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL